NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.070
-0.060 (-2.82%)
Mar 13, 2025, 4:00 PM EDT - Market closed
NRx Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Mar '25 Mar 13, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 35 | 38 | 75 | 281 | 66 | 64 |
| Market Cap Growth | -13.96% | -48.99% | -73.29% | 328.57% | 1.96% | - |
| Enterprise Value | 40 | 39 | 57 | 243 | - | - |
| Last Close Price | 2.13 | 4.60 | 11.10 | 47.80 | 244.00 | 106.00 |
| PB Ratio | -1.87 | -3.26 | 10.13 | 13.51 | -1.50 | -13.26 |
| P/TBV Ratio | - | - | 10.13 | 13.51 | - | - |
| Debt / Equity Ratio | -0.32 | -0.78 | 1.42 | 0.02 | -0.02 | -0.77 |
| Quick Ratio | 0.08 | 0.24 | 1.29 | 2.32 | 0.06 | 0.37 |
| Current Ratio | 0.20 | 0.36 | 1.66 | 2.74 | 0.06 | 0.41 |
| Return on Equity (ROE) | - | - | -281.79% | - | - | - |
| Return on Assets (ROA) | -145.66% | -104.08% | -94.66% | -330.92% | -378.83% | - |
| Return on Capital (ROIC) | - | -224.47% | -141.17% | - | - | - |
| Earnings Yield | -57.79% | -78.73% | -52.95% | -33.11% | -78.94% | -10.46% |
| FCF Yield | -33.24% | -56.56% | -52.96% | -13.41% | -3.46% | -8.62% |
| Buyback Yield / Dilution | -32.95% | -15.20% | -40.17% | -36.90% | -220.58% | - |
| Total Shareholder Return | -32.95% | -15.20% | -40.17% | -36.90% | -220.58% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.